AGENDA

May 10–11, 2023 · Boston, MA
Boston Convention and Exhibition Center

Expand All +

  • Day 1

    May 10, 2023

  • Day 2

    May 11, 2023

  • Entrepreneurship is probably one of the biggest puzzles an engineer can solve. In this opening panel, we'll hear from investors, career experts and entrepreneurs about the process of deciding to leave a corporate engineering job and start your own company.

  • Engineers are critical to all medtech advancement, but start-ups rely on their problem-solving capabilities more than most. In this panel we’ll hear the state of engineering entrepreneurship – engineerpreneurship? - from several different perspectives including investors, career experts and working engineers who can report the state of start-up engineering from the front lines. Is the start-up life for you?
    Keynote

  • Becton Dickinson’s CEO Tom Polen lays out the company’s plan for growth that’s building off a stunning sequence of acquisitions over the past two years that has the company loaded with tech – including digital and robotics tools – to drive its future growth.
    Keynote

  • Explore the expo floor and visit with our exhibitors.

  • Medtech Innovator, the largest medical technology accelerator in the world, has invited top graduates of its program to present their exciting stories to investors, potential partners and other start-up executives.
    Innovation & Investment

  • An interactive panel discussion and review of the challenges and opportunities in developing the market and introducing a novel, motion-preserving solution to restore daily life for underserved pediatric scoliosis patients and their families.
    Engineering, Product Development

  • How can we ensure that MedTech innovation not only enhances patient outcomes but also contributes to a sustainable future? Healthcare's climate footprint is equivalent to >4% of net global carbon emissions, and single use products are on the rise, so there is a pressing need for change. Join us for a thought-provoking discussion on how sustainable design principles can be integrated into medical technology development, highlighting the potential benefits for patients, healthcare providers, and the planet. Discover what we can learn from other market sectors that have already adopted more sustainable principles, informing the role that you can play in building a more resilient and responsible healthcare industry. As an illustration of the potential impact, we will look at high volume diagnostic testing and consider the different aspects of sustainability from manufacture to disposal, looking to the future beyond incremental improvements.
    Engineering, Product Development

  • Medical devices are used to preserve and improve health, but their use can also negatively impact our environment. While patient care and safety are paramount, companies can often use project timelines, budgets, and regulations to push topics like sustainability and environmental impact to the back burner. A lack of discourse around sustainable processes is a common and unnecessary barrier; companies have much to gain from a broader view of best practices. Canon Virginia, Inc. invites its customers and others in the medical device industry to discuss sustainability openly. This discussion will be an engaging survey of topics ranging from business models to product lifecycle management. Joining Canon Virginia will be Gradian Health Systems, a non-profit medical technology company focused on resource-constrained hospitals worldwide.
    Manufacturing, Materials, Sourcing

  • Explore the expo floor and visit with our exhibitors.

  • More advanced heart failure patients could benefit from left ventricular assist devices (LVADs) than are being offered the option. The life-prolonging technology like Abbott’s HeartMate™ 3 is clinically proven to extend life to five years and beyond, yet there are an estimated 15,000 advanced heart failure patients whose median lifespan remains under a year. Social determinants of health are also a critical factor affecting underserved communities who are not being referred early enough. This important message will be illustrated with the inclusion of a LVAD-to-transplant patient on the panel who will share his story from heart failure diagnosis to the seven years of LVAD support that got him to transplant.
    Getting Medtech to Market

  • Tim Laske, Ph.D., Vice President of Research and Business Development, Cardiac Ablation Solutions, will present on the history, knowledge and evolution of nitinol across Medtronic. In this presentation he’ll share how the company has led the way in evolving the application of nitinol within the heart and vasculature, leveraging understanding of its unique properties (flexibility, durability, etc.). He’ll also discuss why Medtronic chose nitinol for Sphere-9, including the considerations around its capabilities and structure within this novel catheter.
    Manufacturing, Materials, Sourcing

  • A growing body of scientific evidence and validation has demonstrated the value of Virtual Reality (VR) vs. Traditional Training across various healthcare specialties. FundamentalVR is a healthcare technology company working at the intersection of immersive technology using VR, haptics (the sense of touch), and machine learning.

    Through its platform that facilitates remote and immersive medical training, medical device, pharmaceutical companies, and healthcare systems are able to enhance skills acquisition and training globally, and as a result accelerate product adoption and drive significant cost savings.

    The session will demonstrate the value of VR and Haptic feedback using real life examples and case studies.
    Engineering, Product Development

  • For technologies developed in university, hospital or other academic settings, it is critical to the success of both parties (sponsor institution and spin out company) that the technology be properly licensed to the company with terms that mutually align the party's interests and will be acceptable to downstream investors, partners, and/or acquirers. Join for a discussion of effective strategies for structuring and negotiating these critical agreements.
    Innovation & Investment

  • Learn about advancements in wireless power and recharging for the next generation of active implantable devices. Unlock new markets, expand your patient population, and strengthen your competitive advantage with these actionable insights.
    Getting Medtech to Market

  • Characterizing the hazards of medical devices has always been a challenge. Materials are at the core challenge as supply chain disruptions have led to the need to alter materials in order to continue production of critical devices. The understanding of toxicology and the effect of chemistry on the human body is evolving in real-time. When you combine all these factors into an industry that is classically slow to alter the charted course – it leads to a perfect storm. We will take a look at what this means to the industry based on our belief that engineering, material selection, and biocompatibility are a three-legged stool in which each has to be effectively balanced all along the way of device manufacturing.
    Manufacturing, Materials, Sourcing

  • In the field of medtech, simulation is revolutionizing patient care by enabling more precise, effective, and efficient healthcare. Companies along all points in the healthcare supply chain are using dynamic, digital representations of their patients, which we refer to as virtual twins, from pre-operative planning to post-operative monitoring. They are able to simulate and test treatments on virtual cohorts when in development and use streams of real-world data fed from sensors to the virtual twin when used in clinical trials and ongoing care. These insights allow medtech organizations to more efficiently bring new products to market, treat and manage patient conditions, improve outcomes and reduce costs. Most importantly, they are essential to creating true patient centric care, allowing the individual to understand their disease, treatment progress and take a proactive approach across the care continuum. This session provides an overview of the progress and visionary potential of Virtual Twins in medtech and highlights the key benefits and challenges of its adoption.

    Learning outcomes for attendees:
    - How this technology can create scale to reach more patients
    - How this technology can anticipate and optimize for patient outcomes
    - How to engage in a collaborative partnership with tech companies to be a part of building this world together.
    Engineering, Product Development

  • Explore the expo floor and visit with our exhibitors.

  • In this interview, DeviceTalks Editorial Director Tom Salemi will interview CEO Mike Mahoney about the course Boston Scientific has taken to emerge as a global medical device leader. Mahoney brings unique perspectives on leadership, risk tasking and knowing when to let a perceived opportunity go.
    Keynote

  • Engineering, high-level imaging, data-collection and analysis are set to boost surgical outcomes by elevating surgeon precision and performance. But how does will these varied technologies – robotics, digital imaging, VR and data analytical tools – mesh? We’ll hear from leaders representing each of those technologies about how the OR of the future will operate.
    Keynote

  • Johnson & Johnson, one of the world’s leading healthcare companies, gives an inside look at the end-to-end development of its Monarch and Ottava robotics platforms, as well as strategy and innovation cadence across surgical robotics for MedTech.
    Keynote

  • Explore the expo floor and visit with our exhibitors.

  • Evidence-based medicine aims to ensure that only the best diagnostics and therapeutics are available to patients in clinical practice. While randomized controlled trials remain the gold standard of clinical evidence, real-world evidence has recently grown in relevance and importance. Spanning sources including electronic medical records, disease registries, insurance claims and consumer wearables, real-world evidence is increasingly used in support of regulatory approvals and market development. In this session, learn how Philips is using real-world evidence to drive clinical adoption of an innovative diagnostic tool for coronary and peripheral interventions called intravascular ultrasound – and how their experience could contribute to your technology’s evidence strategy.
    Engineering, Product Development

  • In this discussion, Tonya Resutek, executive director for respiratory marketing, will speak to how data shows importance of pathologic versus clinical staging for lung cancer. She’ll also discuss the central role of Endobronchial Ultrasound (EBUS) plays in determining lung cancer stage and the ever increasing need for tissue sample sufficiency for next-generation sequencing and personalized cancer medicine. The conversation will also cover the use of Transthoracic Needle Aspiration (TTNA) as a complement to robotic surgery.
    Getting Medtech to Market

  • Join Vicarious Surgical CEO, Adam Sachs, as he discusses his perspectives on the state of surgical visualization today and how software platforms can expand the boundaries of hardware capabilities in surgical robots of the future.
    Manufacturing, Materials, Sourcing

  • Among the many critical issues facing a start-up looking to commercialize a medical device is the choice of a contract manufacturing partner. Our executive panel – comprising both start-up and contract manufacturer perspectives, will raise key points to consider in making this decision. We’ll explore best practices that can lead to savings in time and money, mitigate launch risks, and maximize exit valuations.

  • The medical device industry is facing major headwinds to revenue growth, and many of the challenges are self-inflicted. Sales training that has focused mostly on product and disease-state, messaging campaigns, activity, and rapport-building has left sales professionals ill-equipped to drive results in today’s complex healthcare environment. While more organizations have hired clinicians to diversify their customer-facing teams and help increase product utilization, an aversion to selling is undermining their effectiveness in this new role. A new approach is needed to stem the frustration and turnover and keep revenue growth on target. This session will provide a comprehensive, actionable roadmap for turning “tellers” into valued partners and for equipping everyone with the mindset and skillset for sales success.
    Getting Medtech to Market

  • Real-world data has great promise – but until now, timely insights to inform patient care and regulatory decisions have not been possible. Data has been fragmented, locked behind closed systems, and inaccessible for critical areas like medical device use, making it challenging for life science organizations to carry out safety monitoring and effectiveness studies. But that’s all changing. Medical device makers can now access manufacturer-specific, comprehensive device data linked to longitudinal patient records with deep clinical information to understand the safety and effectiveness of any device. During this session, hear from Truveta about its solution, which offers the most complete and timely picture of US health, with the cleanest data. Learn how leading life science and medical device teams are already unlocking insights.